Skip to main content
Top
Published in: Inflammation 3/2012

01-06-2012

Pre-inflammatory Mediators and Lymphocyte Subpopulations in Preterm Neonates with Sepsis

Authors: Efthalia Hotoura, Vasileios Giapros, Ageliki Kostoula, Polixeni Spyrou, Styliani Andronikou

Published in: Inflammation | Issue 3/2012

Login to get access

Abstract

The aim of this study is to investigate prospectively specific immune system factors in preterm neonates with late-onset sepsis and infection-free controls. Matched preterm neonates (n = 82) were divided into three groups: suspected infection (n = 25), sepsis (n = 17), and infection-free controls (n = 40). Serial measurements were made of interleukin-6 (IL-6), IL-1β, tumor necrosis factor-α (TNF-α), lymphocyte subsets [CD3+, CD4+, CD8+, natural killer (NK) cells, and B cells], the immunoglobulins (IgG, IgM, and IgA), C-reactive protein (CRP), and the total blood count, before, 2 days after initiation of treatment, and after stopping treatment. The percentages of NK and B cells were higher in the sepsis group, but those of CD3+, CD4+, and CD8+ showed no differences. IgG was lower in the sepsis group. IL-6 >30 pg/ml and TNF-α >30 pg/ml were sensitive sepsis predictors with sensitivity 1 (0.78–1) and 1 (0.79–1), respectively, but their specificity was poor. CRP was a specific [0.90 (0.80–0.96)] but not sensitive index [0.68 (0.48–0.85)], and its combination with IL-6 or TNF-α could enhance their diagnostic accuracy. It is concluded that NK and B cells may be elevated in late neonatal sepsis. IL-6 or TNF-α combined with CRP is a good diagnostic marker for late-onset sepsis in preterm neonates.
Literature
1.
go back to reference Mishra, U.K., S.E. Jacobs, L.W. Doyle, and S.M. Garland. 2006. Newer approaches to the diagnosis of early onset neonatal sepsis. Archives of Diseases in Childhood Fetal and Neonatal Edition 91: F208–F212.CrossRef Mishra, U.K., S.E. Jacobs, L.W. Doyle, and S.M. Garland. 2006. Newer approaches to the diagnosis of early onset neonatal sepsis. Archives of Diseases in Childhood Fetal and Neonatal Edition 91: F208–F212.CrossRef
2.
go back to reference Fowlie, P.W., and B. Schmidt. 1998. Diagnostic tests for bacterial infection from birth to 90 days: a systematic review. Archives of Diseases in Childhood Fetal and Neonatal Edition 78: F92–F98.CrossRef Fowlie, P.W., and B. Schmidt. 1998. Diagnostic tests for bacterial infection from birth to 90 days: a systematic review. Archives of Diseases in Childhood Fetal and Neonatal Edition 78: F92–F98.CrossRef
3.
go back to reference Ng, P.C., S.H. Cheng, K.M. Chui, et al. 1997. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birth weight infants. Archives of Diseases in Childhood Fetal and Neonatal Edition 77: F221–F227.CrossRef Ng, P.C., S.H. Cheng, K.M. Chui, et al. 1997. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birth weight infants. Archives of Diseases in Childhood Fetal and Neonatal Edition 77: F221–F227.CrossRef
4.
go back to reference Berner, R., C.M. Niemeyer, J.U. Leititis, et al. 1998. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatric Research 44: 469–477.PubMedCrossRef Berner, R., C.M. Niemeyer, J.U. Leititis, et al. 1998. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatric Research 44: 469–477.PubMedCrossRef
5.
go back to reference Ng, P.C. 2004. Diagnostc markers of infection in neonates. Archives of Diseases in Childhood Fetal and Neonatal Edition 89: F229–F235.CrossRef Ng, P.C. 2004. Diagnostc markers of infection in neonates. Archives of Diseases in Childhood Fetal and Neonatal Edition 89: F229–F235.CrossRef
6.
go back to reference Døllner, H., L. Vatten, and R. Austgulen. 2001. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. Journal of Clinical Epidemiology 54: 1251–1257.PubMedCrossRef Døllner, H., L. Vatten, and R. Austgulen. 2001. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. Journal of Clinical Epidemiology 54: 1251–1257.PubMedCrossRef
7.
go back to reference Mehr, S., and L.W. Doyle. 2000. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatric Infectious Diseases Journal 19: 879–887.CrossRef Mehr, S., and L.W. Doyle. 2000. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatric Infectious Diseases Journal 19: 879–887.CrossRef
8.
go back to reference Buck, C., J. Bundschu, H. Gallati, et al. 1994. Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 93: 54–58.PubMed Buck, C., J. Bundschu, H. Gallati, et al. 1994. Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 93: 54–58.PubMed
9.
go back to reference Giamarellos-Bourboulis, E.J., T. Tsaganos, E. Spyridaki, et al. 2006. Early changes of CD4+-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Critical Care 10: R166.PubMedCrossRef Giamarellos-Bourboulis, E.J., T. Tsaganos, E. Spyridaki, et al. 2006. Early changes of CD4+-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Critical Care 10: R166.PubMedCrossRef
10.
go back to reference Hotchkiss, R.S., S.B. Osmon, K.C. Chang, T.H. Wagner, C.M. Coopersmith, and I.E. Karl. 2005. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. Journal of Immunology 174: 5110–5118. Hotchkiss, R.S., S.B. Osmon, K.C. Chang, T.H. Wagner, C.M. Coopersmith, and I.E. Karl. 2005. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. Journal of Immunology 174: 5110–5118.
11.
go back to reference Gogos, C., A. Kotsaki, A. Pelekanou, et al. 2010. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Critical Care 14: R96.PubMedCrossRef Gogos, C., A. Kotsaki, A. Pelekanou, et al. 2010. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Critical Care 14: R96.PubMedCrossRef
12.
go back to reference Lavoie, P.M., Q. Huang, E. Jolette, et al. 2010. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. Journal of Infectious Diseases 202: 1754–1763.PubMedCrossRef Lavoie, P.M., Q. Huang, E. Jolette, et al. 2010. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. Journal of Infectious Diseases 202: 1754–1763.PubMedCrossRef
13.
go back to reference Celik, I.H., F.G. Demirel, N. Uras, et al. 2010. What are the cut-off levels for IL-6 and CRP in neonatal sepsis? Journal of Clinical Laboratory Analysis 24: 407–412.PubMedCrossRef Celik, I.H., F.G. Demirel, N. Uras, et al. 2010. What are the cut-off levels for IL-6 and CRP in neonatal sepsis? Journal of Clinical Laboratory Analysis 24: 407–412.PubMedCrossRef
14.
go back to reference Santana Reyes, C., F. Garcıa-Munoz, D. Reyes, G. Gonzalez, C. Dominguez, and E. Domenech. 2003. Role of cytokines (interleukin-1, 6, 8, tumour necrosis factor, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatrica 92: 221–227.PubMedCrossRef Santana Reyes, C., F. Garcıa-Munoz, D. Reyes, G. Gonzalez, C. Dominguez, and E. Domenech. 2003. Role of cytokines (interleukin-1, 6, 8, tumour necrosis factor, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatrica 92: 221–227.PubMedCrossRef
15.
go back to reference Hotoura, E., V. Giapros, A. Kostoula, P. Spirou, and S. Andronikou. 2011. Tracking changes of lymphocyte subsets and pre-inflammatory mediators in fullterm neonates with suspected or documented infection. Scandinavian Journal of Immunology 73: 250–255.PubMedCrossRef Hotoura, E., V. Giapros, A. Kostoula, P. Spirou, and S. Andronikou. 2011. Tracking changes of lymphocyte subsets and pre-inflammatory mediators in fullterm neonates with suspected or documented infection. Scandinavian Journal of Immunology 73: 250–255.PubMedCrossRef
16.
go back to reference Pourcyrous, M., H.S. Bada, S.B. Korones, V. Baselski, and S.P. Wong. 1993. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 92: 431–435.PubMed Pourcyrous, M., H.S. Bada, S.B. Korones, V. Baselski, and S.P. Wong. 1993. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 92: 431–435.PubMed
17.
go back to reference Philip, A.G., and P.C. Mills. 2000. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 106: E4.PubMedCrossRef Philip, A.G., and P.C. Mills. 2000. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 106: E4.PubMedCrossRef
18.
go back to reference Benitz, W.E., M.Y. Han, A. Madan, and P. Ramachandra. 1998. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 102: E41.PubMedCrossRef Benitz, W.E., M.Y. Han, A. Madan, and P. Ramachandra. 1998. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 102: E41.PubMedCrossRef
19.
go back to reference Messer, J., D. Eyer, L. Donato, H. Gallati, J. Matis, and U. Simeoni. 1996. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. Journal of Pediatrics 129: 574–580.PubMedCrossRef Messer, J., D. Eyer, L. Donato, H. Gallati, J. Matis, and U. Simeoni. 1996. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. Journal of Pediatrics 129: 574–580.PubMedCrossRef
20.
go back to reference Santana, C., M.C. Guindeo, G. Gonzakz, et al. 2001. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Pediatrica 90: 1176–1181.CrossRef Santana, C., M.C. Guindeo, G. Gonzakz, et al. 2001. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Pediatrica 90: 1176–1181.CrossRef
21.
go back to reference Sofatzis, J., I. Driva, P. Mexi Bourna, G. Liossis, and C. Costalos. 1998. Lymphocyte subpopulations in neonatal sepsis. Prenatal and Neonatal Medicine 3: 353–357. Sofatzis, J., I. Driva, P. Mexi Bourna, G. Liossis, and C. Costalos. 1998. Lymphocyte subpopulations in neonatal sepsis. Prenatal and Neonatal Medicine 3: 353–357.
22.
go back to reference Juretić, E., A. Juretić, B. Uzarević, and M. Petrovecki. 2001. Alterations in lymphocyte phenotype of infected preterm newborns. Biology of the Neonate 80: 223–227.PubMedCrossRef Juretić, E., A. Juretić, B. Uzarević, and M. Petrovecki. 2001. Alterations in lymphocyte phenotype of infected preterm newborns. Biology of the Neonate 80: 223–227.PubMedCrossRef
23.
go back to reference Kotiranta-Ainamo, A., M. Apajasalo, M. Pohjavuori, N. Rautonen, and J. Rautonen. 1999. Mononuclear cell subpopulations in preterm and full-term neonates: independent effects of gestational age, neonatal infection, maternal pre-eclampsia, maternal betamethason therapy, and mode of delivery. Clinical and Experimental Immunology 115: 309–314.PubMedCrossRef Kotiranta-Ainamo, A., M. Apajasalo, M. Pohjavuori, N. Rautonen, and J. Rautonen. 1999. Mononuclear cell subpopulations in preterm and full-term neonates: independent effects of gestational age, neonatal infection, maternal pre-eclampsia, maternal betamethason therapy, and mode of delivery. Clinical and Experimental Immunology 115: 309–314.PubMedCrossRef
24.
go back to reference Aygun, A.D., A.N. Citak Kurt, A. Godekmerdan, et al. 2008. Neonates with culture proven sepsis have lower amounts and percentage of CD4+ 5RA+ T cells. Inflammation 31: 222–226.PubMedCrossRef Aygun, A.D., A.N. Citak Kurt, A. Godekmerdan, et al. 2008. Neonates with culture proven sepsis have lower amounts and percentage of CD4+ 5RA+ T cells. Inflammation 31: 222–226.PubMedCrossRef
25.
go back to reference Leung, B., H.W. Harris. 2010. NKT cells in sepsis. Clinical and Developmental Immunology 2010:pii: 414650 Leung, B., H.W. Harris. 2010. NKT cells in sepsis. Clinical and Developmental Immunology 2010:pii: 414650
26.
go back to reference de Vries, E., S. de Bruin-Versteeg, W.M. Comans-Bitter, et al. 2000. Neonatal blood lymphocyte subpopulations: a different perspective when using absolute counts. Biology of the Neonate 77: 230–235.PubMedCrossRef de Vries, E., S. de Bruin-Versteeg, W.M. Comans-Bitter, et al. 2000. Neonatal blood lymphocyte subpopulations: a different perspective when using absolute counts. Biology of the Neonate 77: 230–235.PubMedCrossRef
27.
go back to reference Sundstrom, Y., C. Nilsson, G. Lilja, K. Karre, M. Troye-Blomberg, and L. Berg. 2007. The expression of human natural killer cell receptors in early life. Scandinavian Journal of Immunology 66: 335–344.PubMedCrossRef Sundstrom, Y., C. Nilsson, G. Lilja, K. Karre, M. Troye-Blomberg, and L. Berg. 2007. The expression of human natural killer cell receptors in early life. Scandinavian Journal of Immunology 66: 335–344.PubMedCrossRef
28.
go back to reference Hodge, G., P. Hodge, P. Han, and R. Haslam. 2004. Multiple leukocyte activation markers to detect neonatal infection. Clinical and Experimental Immunology 135: 125–129.PubMedCrossRef Hodge, G., P. Hodge, P. Han, and R. Haslam. 2004. Multiple leukocyte activation markers to detect neonatal infection. Clinical and Experimental Immunology 135: 125–129.PubMedCrossRef
29.
go back to reference Schoenborn, J.R., and C.B. Wilson. 2007. Regulation of interferon-g during innate and adaptive immune responses. Advances in Immunology 96: 41–101.PubMedCrossRef Schoenborn, J.R., and C.B. Wilson. 2007. Regulation of interferon-g during innate and adaptive immune responses. Advances in Immunology 96: 41–101.PubMedCrossRef
30.
go back to reference van Der Zwet, W.C., C.M. Vandenbroucke-Grauls, R.M. van Elburg, et al. 2002. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics 109: 79–85.CrossRef van Der Zwet, W.C., C.M. Vandenbroucke-Grauls, R.M. van Elburg, et al. 2002. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics 109: 79–85.CrossRef
31.
go back to reference Garty, B.Z., A. Ludomirsky, Y.L. Danon, J.B. Peter, and S.D. Douglas. 1994. Placental transfer of immunoglobulin G subclasses. Clinical and Diagnostic Laboratory Immunology 1: 667–669.PubMed Garty, B.Z., A. Ludomirsky, Y.L. Danon, J.B. Peter, and S.D. Douglas. 1994. Placental transfer of immunoglobulin G subclasses. Clinical and Diagnostic Laboratory Immunology 1: 667–669.PubMed
32.
go back to reference Sandberg, K., A. Fasth, A. Berger, M. Eibl, K. Isacson, A. Lischka, A. Pollak, I. Tessin, and K. Thiringer. 2000. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. Journal of Pediatrics 137: 623–628.PubMedCrossRef Sandberg, K., A. Fasth, A. Berger, M. Eibl, K. Isacson, A. Lischka, A. Pollak, I. Tessin, and K. Thiringer. 2000. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. Journal of Pediatrics 137: 623–628.PubMedCrossRef
33.
go back to reference Kalayci, A.G., B. Adam, F. Yilmazer, S. Uysal, and N. Gurses. 1997. The value of immunoglobulin and complement levels in the early diagnosis of neonatal sepsis. Acta Pediatrica 86: 999–1002.CrossRef Kalayci, A.G., B. Adam, F. Yilmazer, S. Uysal, and N. Gurses. 1997. The value of immunoglobulin and complement levels in the early diagnosis of neonatal sepsis. Acta Pediatrica 86: 999–1002.CrossRef
34.
go back to reference Khassawneh, M., W.A. Hayajneh, H. Kofahi, Y. Khader, Z. Amarin, and A. Daoud. 2007. Diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6 and immunoglobulin M. Scandinavian Journal of Immunology 65: 171–175.PubMedCrossRef Khassawneh, M., W.A. Hayajneh, H. Kofahi, Y. Khader, Z. Amarin, and A. Daoud. 2007. Diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6 and immunoglobulin M. Scandinavian Journal of Immunology 65: 171–175.PubMedCrossRef
Metadata
Title
Pre-inflammatory Mediators and Lymphocyte Subpopulations in Preterm Neonates with Sepsis
Authors
Efthalia Hotoura
Vasileios Giapros
Ageliki Kostoula
Polixeni Spyrou
Styliani Andronikou
Publication date
01-06-2012
Publisher
Springer US
Published in
Inflammation / Issue 3/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9416-3

Other articles of this Issue 3/2012

Inflammation 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine